drugset / Trial / NCT03150368
Extended Use of ModraDoc006/r
NaSingle-groupOpen-labelTreatment
Summary
This is a study for extended use of ModraDoc006/r in patients with advanced solid tumours, available after completed treatment in one of the phase I trials with ModraDoc006/r. The primary goal is to explore the safety of extended use.
Timeline
- Start
- 2017-05-10
- Primary completion
- 2018-05-16
- Completion
- 2019-05-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 10 mg | Oral |
| Background | Ritonavir | Other / unclassified | 100 mg | Oral |